Page 1 | Search Results | Cancer Immunology Research | American Association for Cancer Research

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Abstract B19: FAP CAR T cell therapy for solid tumors with PET imaging

Estela Noguera-Ortega, Iris K Lee, Zebin Xiao, Leslie Todd, John Scholler, Decheng Song, Maria Liousia, Katheryn Lohith, Kexiang Xu, Kimberly J Eduards, Michael D Farwell, Carl H June, Steven M Albelda, Ellen Puré, Mark A Sellmyer

Cancer Immunol Res (2022) 10 (12_Supplement): B19.

https://doi.org/10.1158/2326-6074.TUMIMM22-B19

Published: 01 December 2022

View article titled, Abstract B19: FAP CAR T cell therapy for solid tumors with PET imaging

Journal Articles

Imaging of T-cell Responses in the Context of Cancer Immunotherapy

Zebin Xiao, Ellen Puré

Cancer Immunol Res (2021) 9 (5): 490–502.

https://doi.org/10.1158/2326-6066.CIR-20-0678

Published: 01 May 2021

View article titled, Imaging of T-cell Responses in the Context of Cancer Immunotherapy

Journal Articles

Abstract A62: Inhibition of tumor growth by novel CART redirected against cells expressing high levels of fibroblast activation protein

Estela Noguera-Ortega, Leslie Todd, James Monslow, Jing Sun, Steven M. Albelda, Ellen Pure

Cancer Immunol Res (2020) 8 (3_Supplement): A62.

https://doi.org/10.1158/2326-6074.TUMIMM19-A62

Published: 02 March 2020

View article titled, Abstract A62: Inhibition of tumor growth by novel CART redirected against cells expressing high levels of fibroblast activation protein

Journal Articles

FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors

Cancer Immunol Res (2018) 6 (12): 1472–1485.

https://doi.org/10.1158/2326-6066.CIR-18-0098

Published: 03 December 2018

View article titled, FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors

Includes: Supplementary data

Journal Articles

Seeking Synergy of Checkpoint Blockade through TGFβ Inhibition

Ellen Puré

Cancer Immunol Res (2018) 6 (12): 1444.

https://doi.org/10.1158/2326-6066.CIR-18-0784

Published: 03 December 2018

View article titled, Seeking Synergy of Checkpoint Blockade through TGFβ Inhibition

Journal Articles

Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization

Kheng Newick, Shaun O'Brien, Jing Sun, Veena Kapoor, Steven Maceyko, Albert Lo, Ellen Puré, Edmund Moon, Steven M. Albelda

Cancer Immunol Res (2016) 4 (6): 541–551.

https://doi.org/10.1158/2326-6066.CIR-15-0263

Published: 31 May 2016

View article titled, Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization

Includes: Supplementary data

Journal Articles

Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?

Ellen Puré, Albert Lo

Cancer Immunol Res (2016) 4 (4): 269–278.

https://doi.org/10.1158/2326-6066.CIR-16-0011

Published: 31 March 2016

View article titled, Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?

Journal Articles

Abstract IA18: Tumor stroma: Immunomodulatory functions and a target of immunotherapy

Ellen Puré

Cancer Immunol Res (2016) 4 (1_Supplement): IA18.

https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-IA18

Published: 03 January 2016

View article titled, Abstract IA18: Tumor stroma: Immunomodulatory functions and a target of immunotherapy

Journal Articles

Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Enxiu Wang, Liang-Chuan Wang, Ching-Yi Tsai, Vijay Bhoj, Zack Gershenson, Edmund Moon, Kheng Newick, Jing Sun, Albert Lo, Timothy Baradet, Michael D. Feldman, David Barrett, Ellen Puré, Steven Albelda, Michael C. Milone

Cancer Immunol Res (2015) 3 (7): 815–826.

https://doi.org/10.1158/2326-6066.CIR-15-0054

Published: 01 July 2015

View article titled, Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Includes: Supplementary data

Journal Articles

Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

Liang-Chuan S. Wang, Albert Lo, John Scholler, Jing Sun, Rajrupa S. Majumdar, Veena Kapoor, Michael Antzis, Cody E. Cotner, Laura A. Johnson, Amy C. Durham, Charalambos C. Solomides, Carl H. June, Ellen Puré, Steven M. Albelda

Cancer Immunol Res (2014) 2 (2): 154–166.

https://doi.org/10.1158/2326-6066.CIR-13-0027

Published: 03 February 2014

View article titled, Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

Includes: Supplementary data

NARROW

Abstract B19: FAP CAR T cell therapy for solid tumors with PET imaging

Imaging of T-cell Responses in the Context of Cancer Immunotherapy

Abstract A62: Inhibition of tumor growth by novel CART redirected against cells expressing high levels of fibroblast activation protein

FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors

Seeking Synergy of Checkpoint Blockade through TGFβ Inhibition

Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization

Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?

Abstract IA18: Tumor stroma: Immunomodulatory functions and a target of immunotherapy

Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only